Trial NCT02721875

View at ClinicalTrials.gov 
Org. Study IDs: 1230.43
Secondary IDs: 2015-004490-32

Last trial update was posted on 2018-08-09

MeSH Interventions

Azacitidine

MeSH Conditions

Myelodysplastic Syndromes Preleukemia Syndrome

Other Conditions


Stopping Reasons

N/A

Limitations And Caveats

Trial was prematurely discontinued and only one patient was treated. So it was not possible to draw any conclusion about volasertib monotherapy/with azacitidine, in patients with Myelodysplastic syndrome after Hypomethylating agent treatment failure

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID